CClinicalTrials.gg
CompletedNCT06539065Updated Aug 6, 2024

The Effects of VR Interactive Games on Balance and Quality of Life Enhancement for Elderly in the Community

An interventional study of VR interactive games in Virtual Reality, sponsored by Taipei Medical University. Completed at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-06.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Feb 2023, registered Jun 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn about the effectiveness of the incorporating VR interactive games into exercise courses of the elderly in the community.The main questions It aims to answer are: can It improve their balance ability and the quality of life.

Participants will receive a Twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription, While the control group will follow the original iInstructor-led exercise intervention as the course content.

Read the detailed description

Both groups will undergo three sessions per week, one hour per session, for a total of 12 weeks and 36 sessions of intervention. Before and after competing all sessions, the effectiveness of this intervention will be assessed.

Some physical assessments will be done by all participants such as 2-minute step, right chair sit and reach, left chair sit and reach to compare if any difference between two groups. and participants will do a questionaire to evaluate the psychological and environmental quality of life.

02

Conditions studied

  • Virtual Reality

Keywords

  • VR
  • Balance
  • Quality of life
03

In context

Lead sponsor

Taipei Medical University is the lead sponsor of 245 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Aged 65 or above
  2. Capable of communicating in Mandarin or Taiwanese, and willing to participate in interviews or complete questionnaires
  3. Free of mobility impairments

Exclusion criteria

Exclusion Criteria:

  1. Stroke with sequelae of mobility impairments
  2. Parkinson's disease
  3. Motor neurone disease
  4. Severe Cardio-vascular disease
  5. Degenerative joint disease with flare-ups in past three months
  6. With a lower limb joint surgery in past 3 months
  7. Vertigo
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    VR group

    The experimental group received a twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription

    Device: VR interactive games

  • No intervention
    Non-VR group

    control group followed the original instructor-led exercise intervention as the course content.

Interventions

  • DeviceVR interactive games

    The experimental group received a twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription,

06

What researchers measure

Primary outcomes

  1. Balance ability

    The scores of five physical assessments

    Time frame: Physical assessment done 2 weeks before and 2 weeks after 12 weeks courses

  2. Life quality

    The score of questionnaire done by all participants

    Time frame: Questionnaire done 2 weeks before and 2 weeks after 12 weeks courses

07

Study locations

1 site
  • Taipei medical University
    Taipei, Taiwan
08

References and documents

Study documents

  • Protocol, analysis plan and consent form · Jun 26, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — the datasets generated in this study are available from the corresponding author upon reasonable request.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06539065
Lead sponsor
Taipei Medical University
Responsible party
Sponsor
First posted
Aug 6, 2024
Start date
Feb 13, 2023
Primary completion
Jun 5, 2023
Completion
Jun 15, 2023
Last update
Aug 6, 2024

Study contacts

Chueh-Ho Lin, PhD
study chair · Taipei Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion